Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04616573 · ClinicalTrials.gov registry record · NA
A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma
A NA study, sponsored by Sight Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT04616573 is a NA study that was terminated before completion, run by Sight Sciences. The registered enrollment target is 1 participants.
The verdict
NCT04616573, a NA study, was terminated before completion, sponsored by Sight Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
To prospectively compare the clinical effect of the OMNI surgical system in eyes with Open Angle Glaucoma.
Interventions
- DEVICE OMNI® Surgical System
- DEVICE iStent inject
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2020-11-13 |
| Est. Completion | 2021-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04616573
The ClinicalTrials.gov registry entry for NCT04616573 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sight Sciences, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which OMNI® Surgical System is the first listed.
NCT04616573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04616573 about?
NCT04616573 is a clinical study titled "A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma". To prospectively compare the clinical effect of the OMNI surgical system in eyes with Open Angle Glaucoma.
What is the current status of trial NCT04616573?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2020-11-13. Estimated completion is 2021-01-20.
What interventions are being tested in trial NCT04616573?
The interventions under investigation include: OMNI® Surgical System (DEVICE), iStent inject (DEVICE).
Who is sponsoring clinical trial NCT04616573?
This trial is sponsored by Sight Sciences, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.